The mechanism underlying this elevation in patients with primary lung adenocarcinoma is not known for certain, but it is probably due to overexpression of napsin A on primary lung adenocarcinoma tissue [29] in the alveolar space [20–22]. Here, NAPSA is linked to lung adenocarcinoma.